Fonseca, E, Cabrera-Maqueda, JM, Ruiz-Garcia, R, Naranjo, L, Diaz-Pedroche, C, Velasco, R, Macias-Gomez, A, Milisenda, JC, Munoz-Farjas, E, Pascual-Goni, E, Perez-Larraya, JG, Saiz, A, Dalmau, J, Blanco, Y, Graus, F, Martinez-Hernandez, E. Neurological adverse events related to immune-checkpoint inhibitors in Spain: a retrospective cohort study. LANCET NEUROLOGY. 2023; 22(12)DOI:10.1016/S1474-4422(23)00335-6. PMID:37977714. IF:46.600(Q1/1D).

Bermejo-Guerrero, L, Fernández-de la Hoz, CPD, González-Quereda, L, Segarra-Casas, A, Nedkova, V, Gallano, P, Martín-Jiménez, P, Hernández-Laín, A, Olivé, M, Arteche-López, A, Domínguez-González, C. Distal myopathy due to digenic inheritance of TIA1 and SQSTM1 variants in two unrelated Spanish patients. NEUROMUSCULAR DISORDERS. 2023; 33(12)DOI:10.1016/j.nmd.2023.10.016. PMID:38016875. IF:2.700(Q2/4D).

Liberatore, G, De Lorenzo, A, Giannotta, C, Manganelli, F, Filosto, M, Cosentino, G, Cocito, D, Briani, C, Cortese, A, Fazio, R, Lauria, G, Clerici, AM, Rosso, T, Marfia, GA, Antonini, G, Cavaletti, G, Carpo, M, Doneddu, PE, Spina, E, Piccinelli, SC, Peci, E, Querol, L, Nobile-Orazio, E. Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database (vol 43, pg 3939, 2022). NEUROLOGICAL SCIENCES. 2023; DOI:10.1007/s10072-023-07184-y. PMID:38008812. IF:2.700(Q2/4D).

Broers, MC, Wieske, L, Erdag, E, Gürlek, C, Bunschoten, C, van Doorn, PA, Eftimov, F, Kuitwaard, K, de Vries, JM, de Wit, MCY, Nagtzaam, MMP, Franken, SC, Zhu, LIS, Paunovic, M, de Wit, M, Schreurs, MWJ, Lleixà, C, Martín-Aguilar, L, Pascual-Goñi, E, Querol, L, Jacobs, BC, Huizinga, R, Titulaer, MJ. Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2023; 95(1)DOI:10.1136/jnnp-2023-331378. PMID:37879898. IF:8.800(Q1/1D).

Meca-Lallana J.E., Prieto González J.M., Caminero Rodríguez A.B., Olascoaga Urtaza J., Alonso A.M., Durán Ferreras E., Espinosa R., Dotor J., Romera M., Ares Luque A., Pérez Ruiz D., Calles C., Hernández M.A., Hervás García M., Mendoza Rodríguez A., Berdei Montero Y., Téllez N., Herrera Varó N., Sotoca J., Presas-Rodríguez S., Querol Gutierrez L.A., Hervás Pujol M., Batlle Nadal J., Martín Ozaeta G., Gubieras Lillo L., Martínez Yélamos S., Ramió-Torrentà L., Mallada Frechin J., Belenguer Benavides A., Gascón-Giménez F., Casanova B., Landete Pascual L., Berenguer L., Navarro L., Gómez Gutierrez M., Durán C., Rodríguez Regal A., Álvarez E., García-Estévez D.A., López Real A.M., Llaneza González M.A., Marzo Sola M.E., Sánchez-Menoyo J.L., Oterino A., Villaverde González R., Castillo-Triviño T., Álvarez de Arcaya A., Llarena C.. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study. Neurology and Therapy. 2023; 12(6)DOI:10.1007/s40120-023-00557-7. PMID:37861931. IF:4.000(Q1/2D).

van Doorn P.A., Van den Bergh P.Y.K., Hadden R.D.M., Avau B., Vankrunkelsven P., Attarian S., Blomkwist-Markens P.H., Cornblath D.R., Goedee H.S., Harbo T., Jacobs B.C., Kusunoki S., Lehmann H.C., Lewis R.A., Lunn M.P., Nobile-Orazio E., Querol L., Rajabally Y.A., Umapathi T., Topaloglu H.A., Willison H.J.. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome. EUROPEAN JOURNAL OF NEUROLOGY. 2023; 30(12)DOI:10.1111/ene.16073. PMID:37814552. IF:4.500(Q1/2D).

van Doorn P.A., Van den Bergh P.Y.K., Hadden R.D.M., Avau B., Vankrunkelsven P., Attarian S., Blomkwist-Markens P.H., Cornblath D.R., Goedee H.S., Harbo T., Jacobs B.C., Kusunoki S., Lehmann H.C., Lewis R.A., Lunn M.P., Nobile-Orazio E., Querol L., Rajabally Y.A., Umapathi T., Topaloglu H.A., Willison H.J.. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2023; 28(4)DOI:10.1111/jns.12594. PMID:37814551. IF:4.000(Q1/2D).

Esteller D., Schiava M., Villar-Quiles, RN, Dibowski B., Venturelli N., Laforet P., Alonso-Pérez J., Olive M., Domínguez-González C., Paradas C., Vélez B., Kostera-Pruszczyk A., Kierdaszuk B., Rodolico C., Claeys K., Pál E., Malfatti E., Souvannanorath S., Alonso-Jiménez A., de Ridder W., De Smet E., Papadimas G., Papadopoulos C., Xirou S., Luo S., Muelas N., Vilchez J.J., Ramos-Fransi A., Monforte M., Tasca G., Udd B., Palmio J., Sri S., Krause S., Schoser, B, Fernández-Torrón R., de Munain, AL, Pegoraro E., Farrugia M.E., Vorgerd M., Manousakis G., Chanson J.B., Nadaj-Pakleza A., Cetin H., Badrising U., Warman-Chardon J., Bevilacqua J., Earle N., Campero M., Díaz J., Ikenaga C., Lloyd T.E., Nishino I., Nishimori Y., Saito Y., Oya Y., Takahashi Y., Nishikawa A., Sasaki R., Marini-Bettolo C., Guglieri M., Straub V., Stojkovic T., Carlier R.Y., Díaz-Manera J.. Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis. JOURNAL OF NEUROLOGY. 2023; 270(12)DOI:10.1007/s00415-023-11862-4. PMID:37603075. IF:4.800(Q1/2D).